Advanced capability for translational medicines manufacturing
Located within the University of Strathclyde, CMAC’s National Facility is a purpose-built 900m2 environment providing access to future-ready technologies, specialist expertise, and integrated digital systems.
A different kind of research partner
-

WHO WE ARE
CMAC is a publicly funded national research centre, not a contract research organisation. That distinction matters. When you work with us, you're not buying analytical time — you're accessing a multidisciplinary scientific community that will help you understand why your process behaves the way it does, and how to design it better from the outset.
-

WHO WE WORK WITH
We collaborate with organisations of all sizes, academic institutions, technology developers and innovation partners.
-

OUR APPROACH
We deliver agile, data‑driven solutions through advanced facilities, integrated digital tools and specialist expertise, providing flexible, end‑to‑end support that accelerates high‑quality, efficient medicines development.
Transforming medicines development from molecule to market
We deliver agile, data-driven R&D supporting discovery, particle engineering, crystallisation, formulation development, continuous drug product manufacturing and advanced analytics.
Our approach integrates digital CMC principles — real-time data capture, model-informed development, AI/ML tools, and connected knowledge graph infrastructure — to transition laboratory concepts into industrially relevant processes that support faster, safer, and more flexible medicines manufacturing.
Core capabilities
-
Taking continuous manufacturing from synthesis to final form - reducing cycle times, improving consistency and enabling real-time quality control.
-
Our digital CMC infrastructure is designed to make your results more valuable over time: structured, connected and ready to power AI-enabled pharmaceutical development.
-
Targeted analytical, modelling and process-design grounded in digital CMC, enabling predictive control and accelerated process understanding.
Engagement pathways
-
End-to-end R&D for complex pharmaceutical development challenges.
-
Hands-on use of our technology platforms with expert technical support.
-
Targeted analytics, modelling, troubleshooting and specialist expertise on demand.
Our research and consultancy services span the full development pipeline:
-

X-Ray Diffraction and Solid State Characterisation
With expertise spanning powder and single-crystal diffraction, spectroscopy, imaging and advanced solid-state analysis, CMAC provides comprehensive structural characterisation solutions for pharmaceutical and advanced materials development.
-

Drug Product
With 30+ validated predictive modelling tools, bespoke equipment, and expertise across secondary manufacturing, we enable faster, more confident decisions, from first milligram to commercial scale.
-

Crystallisation
From early-stage screening to continuous manufacturing, CMAC's crystallisation team delivers rapid, model-informed process development, giving you reliable control of particle size, polymorph, and yield with minimal material investment.
-

Nanomedicine
Page coming soon. Contact us to learn about our nanomedicine capabilities.
-

Analytics
Page coming soon. Contact us to learn about our analytical capabilities.
Why work with CMAC?
-
End-to-End Support
Integrated services across drug substance, drug product, and analytics under one roof.
-
Industry-aligned research
Co-created with global pharmaceutical partners, directly aligned to real manufacturing challenges.
-
Accelerated development
Streamlined, data-driven workflows and digital tools get you to market faster with fewer experiments.
-
Proven track record
A strong history of solving complex industrial challenges with global pharmaceutical partners.
-
Multidisciplinary expertise
Chemistry, pharmaceutics, engineering, analytics and modelling experts, working as one team.
-
Flexible access
Engage with us on your terms, whether it's full project delivery, technical consultancy, or one-off support.
From molecule to market customer stories
Discovery to Particle Engineering:
“CMAC’s particle engineering support accelerated our API readiness, giving us material suitable for continuous processing far earlier than expected.”
— Former CustomerFormulation & Continuous Processing:
“The continuous direct compression expertise at CMAC significantly improved our material performance and reduced development cycle times.”
— Former CustomerDigital CMC & Analytics:
“The digital workflows and model‑informed approaches helped us identify optimal operating conditions with far fewer experiments.”
— Former CustomerReady to collaborate?